Related Experiment Video
Updated: Jul 13, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Therapy-resistant hypertension--the endocrinological view]
1Medizinische Klinik Innenstadt, Ludwig-Maximilians-Universität München. felix.beuschlein@med.uni-muenchen.de
Abstract:
A significant percentage of patients with therapy-resistant high blood pressure have hormonal hypertension. This includes primary hyperaldosteronism due to an aldosterone-producing adenoma, or a bilateral adrenal hyperplasia, hypercortisolism caused by a tumor of the adrenals, or an ACTH-dependent form of Cushing's syndrome, as also excessive catecholamines caused by a pheochromocytoma or a paraganglioma. The diagnostic work-up includes screening tests for the basal hormone status in the serum and urine, together with confirmatory additional hormonal and imaging procedures in suspected cases, or to establish a differential diagnosis. In addition to surgical treatment, specific pharmacotherapeutic measures for the prevention or follow-up treatment of excess adrenal hormones are available.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension III: Clinical Manifestations and Diagnostic Studies
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension and Regulation of Blood Pressure